Notably, the most immediate risk of IF is hypoglycemia in patients taking hypoglycemic medications, particularly insulin (both postprandial and basal) and sulfonylureas (including short-acting metronidazole), and caution should be exercised when administering IF to this group of patients (111). This evidence concerns the gene INS and Hypoglycemia.